Discussion Phage therapy is a promising alternative for the treatment of difficult-to-treat infections, and could be a key component in the battle against antimicrobial resistance.

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...

You can notice signs of HIV on the tongue during the early and late stages of the infection with the virus. An acute HIV ...

Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...

Oral cancer, affecting areas from the lips to the oropharynx, often starts subtly, emphasizing the importance of regular ...

The FDA has approved Sobi's Gamifant (emapalumab) to treat adults and children with HLH/MAS associated with Still’s disease, including sJIA.

This finding suggests that boosting ApoM in older adults could become a new way to treat or even prevent AMD—before vision is lost.

Colorado's HB24-1045 bill, effective July 1, 2025, broadens substance use disorder treatment for individuals post-incarceration.

The treatment of most cases of acute promyelocytic leukemia differs from usual AML treatment. Learn more about APL treatment here.